Overall impact
B (61)

Commentary

Bayer is a strong overall performer. With a 'B' rating of 61.3 for overall impact (65th percentile compared to all companies), Bayer ranks 185th out of 257 industry peers, behind Genetic S.p.A., Catalyst Pharmaceuticals, Agios Pharmaceuticals and 181 others, and ahead of Akorn, PPD Incorporated, Azurity Pharmaceuticals and 69 others. On top material causes for Bayer's industry (Pharmaceuticals), Bayer performs well in Improved Mental Health (95.2 score), Equal Pay and Opportunity (95.2), Child and Maternal Health (87.2) and 33 other causes where it received an 'A' score and performs poorly in Child and Maternal Health (9.0 score), Child and Maternal Health (9.0), Accountable Institutions (0.0) and 57 other causes where it received a 'D' or 'F' score.
Screens
Fur
Impact
Cause BAYZF
Peer rank
Overall impact

Log in to view this information

Screens
Fur
Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
87,757
Sector
Health Care
Industry
Pharmaceuticals
Sub-industry
Pharmaceuticals
SASB industry
Biotechnology & Pharmaceuticals
Headquarters
Germany
Share classes
BAYRY
ADR
BAYZF
Mission
Science For A Better Life.
Description
Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, pain and cardiovascular risk prevention products, digestive health products, allergy products, and cold and cough products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
Material causes
Ethos considers the following causes material for Bayer, based on its industry sub-industry Pharmaceuticals. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.